Disc Medicine elects Nadim Ahmed as Class I director effective July 14, 2025

Disc Medicine, Inc.

Nadim Ahmed elected to Board as Class I director, term until 2027 annual meeting.
Ahmed receives $40,000 annual cash retainer and a 20,000-share option vesting over three years.
Ahmed enters into standard indemnification agreement with the Company.
No arrangements or material transactions with other persons disclosed.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.